CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,327 | +27.8% | 48,685 | +4.4% | 0.00% | – |
| Q2 2023 | $1,038 | +4.5% | 46,643 | +1.8% | 0.00% | – |
| Q1 2023 | $993 | +12.1% | 45,811 | +5.0% | 0.00% | – |
| Q4 2022 | $886 | -99.9% | 43,610 | +5.0% | 0.00% | – |
| Q3 2022 | $1,065,000 | +25.1% | 41,528 | +16.0% | 0.00% | – |
| Q2 2022 | $851,000 | +32.3% | 35,797 | +25.3% | 0.00% | – |
| Q1 2022 | $643,000 | +32.3% | 28,567 | +16.4% | 0.00% | – |
| Q4 2021 | $486,000 | -42.3% | 24,537 | -42.6% | 0.00% | – |
| Q3 2021 | $842,000 | -10.0% | 42,763 | +0.5% | 0.00% | – |
| Q2 2021 | $936,000 | -4.0% | 42,563 | +3.8% | 0.00% | – |
| Q1 2021 | $975,000 | -9.4% | 41,002 | -0.3% | 0.00% | – |
| Q4 2020 | $1,076,000 | +66.8% | 41,137 | -53.7% | 0.00% | – |
| Q4 2016 | $645,000 | +37.2% | 88,815 | -11.6% | 0.00% | – |
| Q1 2016 | $470,000 | -6.0% | 100,454 | 0.0% | 0.00% | – |
| Q4 2015 | $500,000 | -65.6% | 100,454 | -74.0% | 0.00% | – |
| Q3 2015 | $1,454,000 | – | 386,635 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |